On the other hand, high-grade MIBC or metastatic bladder cancer, including carcinoma in situ, is characterized by loss-of-function mutations affecting tumor suppressor genes, such as TP53, RB, or PTEN25. The gene discussed is TP53; the disease is in situ carcinoma.